Home
Conditions
Hepatitis, Chronic

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy

NCT02060058

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +17 more
Locations: Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. Kaohsiung City, Taiwan

View Trial Details

Completed

The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects

NCT03462173

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C

NCT03453346

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Chinese PLA 302 Hospital Beijing, Beijing Municipality, China

Peking University People's Hospital Beijing, Beijing Municipality, China

Capital Medical University Affiliated Beijing Youyi Hospital Beijing, Beijing Municipality, China

Capital Medical University Affiliated Beijing You'an Hospital Beijing, Beijing Municipality, China

View all 17 locations

View Trial Details

Completed

EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) Infection

NCT03320616

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: PRA-EDS Groningen, Netherlands

View Trial Details

Completed

An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C

NCT01679834

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Hanover, Germany

Herne, Germany

View Trial Details

Completed

A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection

NCT02068222

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C

NCT03416491

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

Capital Medical University Affiliated Beijing Youyi Hospital Beijing, Beijing Municipality, China

Capital Medical University Affiliated Beijing You'an Hospital Beijing, Beijing Municipality, China

Chinese PLA Third Military Medical University First Affiliated Hospital Chongqing, Chongqing Municipality, China

View Trial Details

Completed

Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B

NCT01926288

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Department of Infectious Diseases,Peking University First Hospital Beijing, Beijing Municipality, China

Beijing You An Hospital,Capital Medical University Beijing, Beijing Municipality, China

The First Affiliated Hospital Of The Third Mililary Medical University Chongqing, Chongqing Municipality, China

Tongji Medical College of Hust Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Completed

A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

NCT02356562

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C

NCT01790100

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Arensia, Republican Clinical Hospital Chisinau, Moldova

View Trial Details

Hepatitis, Chronic

Hepatitis, Chronic trial results

Related conditions